The CLINAM Summit is a globally unique event that brings together all stakeholders in nanomedicine, targeted medicine and precision medicine. Santi Sala, from Nanomol Technologies has participated into the session Presentations on Nanoparticles – Analytics, Methods and Technologies by presenting the work Technology platform for the production of lipid-based nanovesicles as new nanomedicines. By this presentation he has described latest developments related to our Horizon 2020 project “Smart-4-Fabry” – Smart multifunctional GLA-nanoformulation for Fabry disease.